Fifth Annual Psychopharmacology Update

GME&rsquo s annual Psychopharmacology Update features the world&rsquo s leading experts in psychiatry who discuss the latest advances in the pharmacotherapy of anxiety mood disorders schizophrenia and more.

Share

Program Content

Activities

  • Pharm of Movemt Dis
    Pharmacotherapy of Antipsychotic-Induced Movement Disorders
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of ADHD
    Pharmacotherapy of ADHD Across the Lifecycle
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharmacotherapy of Anx Dis
    Pharmacotherapy of Anxiety Disorders
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of Bipolar
    Pharmacotherapy of Bipolar Depressive Spectrum Disorders
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of Eating Disorders
    Pharma of Eating Disorders
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharmacotherapy of PPD
    Pharmacotherapy of Premenstrual, Perimenopausal, and Postpartum Depression
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of Psych Disorders
    Pharmacotherapies for Psychiatric Disorders: What Does the Future Hold?
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Side Effects of Psych Meds
    Managing Side Effects of Psychiatric Medications
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of Schizophrenia
    Pharmacotherapy of Schizophrenia
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of Sleep
    Pharmacotherapy of Narcolepsy and Insomnia
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

  • Pharma of TRD
    Pharmacotherapy of Treatment-Resistant Major Depression
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2020

    Expires: March 15, 2021

Faculty

cover img faculity

Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

cover img faculity

Milton Erman, MD

Voluntary Clinical Professor in the Department of Psychiatry
University of California San Diego School of Medicine
San Diego, California

cover img faculity

Joseph H. Friedman, MD

Professor and Chief
Division of Movement Disorders
Department of Neurology
Warren Alpert Medical School of Brown University
Providence, Rhode Island

cover img faculity

Prakash Masand, MD

Chief Medical Officer
Clinical Education Alliance
Adjunct Professor
Duke-NUS
New York, New York

cover img faculity

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University
President
Midwest Research Group
President Elect
American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

cover img faculity

Jeffrey Newcorn, MD

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Neurocrine Biosciences

Sunovion

Takeda

Tris Pharmaceuticals

Partners

GME

ProCE Banner